EUDA
EUDA Health Holdings Limited
NASDAQ: EUDA · REAL ESTATE · REAL ESTATE SERVICES
$14.38
+0.38% today
Updated 2026-06-02
Market cap
$48.09M
P/E ratio
—
P/S ratio
7.05x
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$5 – $86
Volume
0.1M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-47.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$55.00
+282.48%
12-Month target
$11.44
-20.45%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Revenue growth 78.90% QoQ
+ Debt/equity -0.56x — low leverage
Risks
- Altman Z -47.30 — distress zone
- Thin margins at -40.70%
- Negative free cash flow $-2.53M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.76M | $3.71M | $4.01M | $6.82M | $6.82M |
| Net income | $-24.88M | $-10.04M | $-15.36M | $-2.77M | $-2.77M |
| EPS | — | — | — | — | $-1.48 |
| Free cash flow | $-1.54M | $-2.92M | $-2.15M | $-2.53M | $-2.53M |
| Profit margin | -661.06% | -270.86% | -382.87% | -40.65% | -40.70% |
Peer comparison
Smart narrative
EUDA Health Holdings Limited trades at $14.38. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -47.30, it sits in the distress. TTM revenue stands at $6.82M. with profit margins at -40.70%.
Frequently asked questions
What is EUDA Health Holdings Limited's stock price?
EUDA Health Holdings Limited (EUDA) trades at $14.38, on a P/S of 7.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is EUDA Health Holdings Limited overvalued?
EUDA Health Holdings Limited carries a Smart Value Score of 24/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of EUDA Health Holdings Limited (EUDA)?
The 12-month analyst consensus target is $55.00, about 282.5% above the current $14.38. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is EUDA Health Holdings Limited's revenue?
EUDA Health Holdings Limited's trailing twelve-month revenue is $6.82M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
EUDA Health Holdings Limited's Altman Z-Score is -47.30, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorREAL ESTATE
IndustryREAL ESTATE SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio7.05x
ROE—
Beta0.64
50D MA$12.24
200D MA$32.00
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—